Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
about
The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophyX-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolismAbcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient micePathophysiology of X-linked adrenoleukodystrophy.Identification of atypical ether-linked glycerophospholipid species in macrophages by mass spectrometry.Histone deacetylase inhibitor upregulates peroxisomal fatty acid oxidation and inhibits apoptotic cell death in abcd1-deficient glial cells.Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid--a case report.HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control studyThe X-linked adrenoleukodystrophy (X-ALD) and oxidative stress.Neurodegeneration in a Drosophila model of adrenoleukodystrophy: the roles of the Bubblegum and Double bubble acyl-CoA synthetases.Fast diffusion of very long chain saturated fatty acids across a bilayer membrane and their rapid extraction by cyclodextrins: implications for adrenoleukodystrophy.Peroxisomes, myelination, and axonal integrity in the CNS.Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy.Myelin lesions associated with lysosomal and peroxisomal disorders.X-linked adrenoleukodystrophy: pathogenesis and treatment.Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy.Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy.Evidence for two enzymatic pathways for omega-oxidation of docosanoic acid in rat liver microsomes.Uptake and metabolism of plasma-derived erucic acid by rat brain.Brain microsomal fatty acid elongation is increased in abcd1-deficient mouse during active myelination phase.MicroRNA Profiling Identifies miR-196a as Differentially Expressed in Childhood Adrenoleukodystrophy and Adult Adrenomyeloneuropathy.Method for Measurement of Peroxisomal Very Long-Chain Fatty Acid Beta-Oxidation and De Novo C26:0 Synthesis Activity in Living Cells Using Stable-Isotope Labeled Docosanoic Acid.
P2860
Q24300003-1073B39F-F034-4CD9-8B13-79511361A5ACQ30460666-AA9C3B7E-99C7-49EE-857C-66C5FD551983Q34116305-4627FD2A-5B57-41E1-A6FD-56AA04F2D7B6Q34257373-BB2C0A55-3600-4A28-A21A-3E04BCB82859Q34390414-CC67C942-5A0F-4C30-B576-275FD0264F32Q34559994-5EF05FFD-6442-4BEA-BCD5-429F1DC19538Q34907267-DD3B6D75-FACA-4FCA-9E39-310345C8E131Q35225619-9A2C81B9-C1D3-4C62-B1A8-E33CD730D178Q35380239-8E222D13-6400-4008-8846-B11C698D45D6Q35417932-1B080CB0-229D-46D7-AE6F-8299CF1DFC53Q35756786-07D364E3-200F-492D-8DDD-3268473601D4Q36743396-1D8714A1-211A-4C6A-BF07-C1B81B4E4359Q36856014-55DE6EB6-573B-4439-BA3C-82D5A69943E7Q37446137-E2E1A183-ECEC-4C28-A186-0E8C1EBE2552Q37576855-E10B352F-6C5A-4B6E-9532-D25C6BF490ADQ37596791-CBB3BAE2-BC9F-444C-83E9-2B0E096417D6Q37785556-1D1EA815-7D28-47E1-92E1-8F0BE1CF15F8Q38239213-00AACFD3-0318-4326-AA8D-B021AC96F64FQ38867787-0BB63DDE-0604-42EA-819B-11086785D730Q42770360-ACC8405F-3362-462B-A07A-679B005BAFB3Q43152628-3C5BDBF4-5ADC-45F7-A8EE-811B030576B9Q45270091-D370AAD4-6353-4E81-B381-275FBF19C957Q46981518-8D623394-C5FD-4306-8ABA-AA94A36C0BEEQ48111114-AAC3C08A-8CF0-4133-A1B5-636E98F8046BQ53276010-D49C9277-65A4-4F96-AE60-B264F3983D3AQ53505330-D55322FB-1E08-494C-9F76-B4BEE939222E
P2860
Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
@en
Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
@nl
type
label
Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
@en
Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
@nl
prefLabel
Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
@en
Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
@nl
P2093
P1476
Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
@en
P2093
Fredoen Valianpour
Peter G Barth
Petra Mooyer
Robert-Jan Sanders
Simone Denis
P304
P356
10.1016/J.YMGME.2004.09.015
P577
2005-02-01T00:00:00Z